BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 27, 2012
View Archived Issues
Promising data disclosed on apremilast in psoriasis and atopic dermatitis
Read More
UCB provides pipeline progress report for 2011
Read More
U.S. study reveals new prognostic marker of aggressive kidney cancer
Read More
New PET imaging agents designed at Bayer Schering Pharma
Read More
University of California, Oakland divulges novel diagnostics
Read More
New boron-based ROCK inhibitors show potential to treat inflammation and hypertension
Read More
GenVec receives NIAID grant for vaccine program
Read More
ScinoPharm and NHRI to begin phase I trial of DBPR-108
Read More
FDA approves dry nasal aerosol product for allergic rhinitis
Read More
Merck & Co. selects new agent for development in diabetes
Read More
EMA accepts lorcaserin MAA for review
Read More
Clavis Pharma provides update relating to phase III CLAVELA trial
Read More
First descriptions provided of BMS products now in phase II testing
Read More
Celtic Therapeutics launches new company
Read More
Nippon Shinyaku seeks approval of drug for persons with alcohol dependence
Read More
New antibodies designed to treat and prevent influenza
Read More
New candidate cancer therapies presented
Read More
Novel IL-18R1-binding antibodies presented by Roche
Read More
Neurocrine Biosciences reports on phase II study in tardive dyskinesia
Read More
Astellas Pharma files MAA for new fixed-dose combination tablet for LUTS
Read More
CSL Behring kicks off enrollment in PATH trial
Read More
Cell Therapeutics gives update on Opaxio study in GBM
Read More
FDA issues complete response letter for Levadex NDA
Read More
Medgenics receives recommendations from NIH committee for phase II trial
Read More
Insys Therapeutics launches fentanyl sublingual spray in U.S.
Read More